| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |